Shares of RTW Biotech Opportunities (LON:RTW – Get Free Report) were up 0.3% on Monday . The stock traded as high as GBX 1.56 ($0.02) and last traded at GBX 1.54 ($0.02). Approximately 103,208 shares were traded during trading, a decline of 85% from the average daily volume of 679,371 shares. The stock had previously closed at GBX 1.54 ($0.02).
RTW Biotech Opportunities Price Performance
The firm has a 50 day moving average of GBX 1.40 and a two-hundred day moving average of GBX 1.36. The stock has a market cap of £5.92 million, a PE ratio of 4.28 and a beta of 0.60.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Stories
- Five stocks we like better than RTW Biotech Opportunities
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- The Top 3 Sectors Poised For Growth This Summer
- What Are Dividends? Buy the Best Dividend Stocks
- U.S. Steel Stock: Betting on EPS Cut and Merger Uncertainty?
- 5 Top Rated Dividend Stocks to Consider
- GitLab Stock: Pioneering the AI-Powered DevSecOps Platform
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
